NSAID exacerbated respiratory disease

Clinical trials for NSAID exacerbated respiratory disease

3 trials across Europe

See all trials →

Quick filters

3 Clinical trials

NSAID exacerbated respiratory disease

Not recruiting

Study on Aspirin's Role in Reducing COVID-19 Risk for Patients with Aspirin-Exacerbated Respiratory Disease

Registered drug

Study on Aspirin's Role in Reducing COVID-19 Risk for Patients with Aspirin-Exacerbated Respiratory Disease

Registered drug

Poland

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Acetylsalicylic Acid
Sponsor:Uniwersytet Jagiellonski Collegium Medicum

Contact Research Centre

NSAID exacerbated respiratory disease

Not recruiting

Study of intranasal lysine-aspirin effectiveness in patients with NSAID-exacerbated respiratory disease (N-ERD)

Registered drugNo placebo

Study of intranasal lysine-aspirin effectiveness in patients with NSAID-exacerbated respiratory disease (N-ERD)

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Acetylsalicylic Acid
Sponsor:UZ Leuven

Contact Research Centre

NSAID exacerbated respiratory disease

Not recruiting

Study on the Long-term Effects of Dupilumab for Patients with Aspirin-Exacerbated Respiratory Disease (AERD)

Registered drugNo placebo

Study on the Long-term Effects of Dupilumab for Patients with Aspirin-Exacerbated Respiratory Disease (AERD)

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Dupilumab
Sponsor:Medical University Of Vienna